Report

  1. Home
  2. Global

Respiratory Syncytial Virus Vaccine Market (Vaccine Type: Recombinant/Subunit Vaccines, mAB Injection, mRNA Vaccines and Others; Age Group: Adults & Geriatrics and Children & Pregnant Mothers; and Sales Channel: Retail Pharmacies, Hospital Pharmacies and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

Market Report I 2025-04-23 I 175 Pages I Transparency Market Research

Respiratory Syncytial Virus Vaccine Market - Scope of Report
TMR's report on the global respiratory syncytial virus vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global respiratory syncytial virus vaccine market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global respiratory syncytial virus vaccine market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the respiratory syncytial virus vaccine market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global respiratory syncytial virus vaccine market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global respiratory syncytial virus vaccine market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global respiratory syncytial virus vaccine market.

The report delves into the competitive landscape of the global respiratory syncytial virus vaccine market. Key players operating in the global respiratory syncytial virus vaccine market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global respiratory syncytial virus vaccine market profiled in this report.

Key Questions Answered in global respiratory syncytial virus vaccine Market Report
- What is the sales/revenue generated by respiratory syncytial virus vaccine across all regions during the forecast period?
- What are the opportunities in the global respiratory syncytial virus vaccine market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2035?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?

Respiratory Syncytial Virus Vaccine Market - Research Objectives and Research Approach
The comprehensive report on the global respiratory syncytial virus vaccine market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global respiratory syncytial virus vaccine market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global respiratory syncytial virus vaccine market.

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Respiratory Syncytial Virus Vaccine Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Respiratory Syncytial Virus Vaccine Market Analysis and Forecasts, 2020-2035
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Healthcare Expenditure Data Across Key Countries
5.2. Technological Advancements
5.3. Regulatory Scenario across Key Regions / Countries
5.4. PORTER's Five Forces Analysis
5.5. PESTEL Analysis
5.6. Key Industry Events
6. Global Respiratory Syncytial Virus Vaccine Market Analysis and Forecasts, By Vaccine Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Vaccine Type, 2020-2035
6.3.1. Recombinant/Subunit Vaccines
6.3.2. mAB Injection
6.3.3. mRVaccines
6.3.4. Others
6.4. Market Attractiveness By Vaccine Type
7. Global Respiratory Syncytial Virus Vaccine Market Analysis and Forecasts, By Age Group
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Age Group, 2020-2035
7.3.1. Adults & Geriatrics
7.3.2. Children & Pregnant Mothers
7.4. Market Attractiveness By Age Group
8. Global Respiratory Syncytial Virus Vaccine Market Analysis and Forecasts, By Sales Channel
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sales Channel, 2020-2035
8.3.1. Retail Pharmacies
8.3.2. Hospital Pharmacies
8.3.3. Others
8.4. Market Attractiveness By Sales Channel
9. Global Respiratory Syncytial Virus Vaccine Market Analysis and Forecasts, By Region
9.1. Key Findings
9.2. Market Value Forecast By Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Region
10. North America Respiratory Syncytial Virus Vaccine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Vaccine Type, 2020-2035
10.2.1. Recombinant/Subunit Vaccines
10.2.2. mAB Injection
10.2.3. mRVaccines
10.2.4. Others
10.3. Market Value Forecast By Age Group, 2020-2035
10.3.1. Adults & Geriatrics
10.3.2. Children & Pregnant Mothers
10.4. Market Value Forecast By Sales Channel, 2020-2035
10.4.1. Retail Pharmacies
10.4.2. Hospital Pharmacies
10.4.3. Others
10.5. Market Value Forecast By Country, 2020-2035
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Vaccine Type
10.6.2. By Age Group
10.6.3. By Sales Channel
10.6.4. By Country
11. Europe Respiratory Syncytial Virus Vaccine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Vaccine Type, 2020-2035
11.2.1. Recombinant/Subunit Vaccines
11.2.2. mAB Injection
11.2.3. mRVaccines
11.2.4. Others
11.3. Market Value Forecast By Age Group, 2020-2035
11.3.1. Adults & Geriatrics
11.3.2. Children & Pregnant Mothers
11.4. Market Value Forecast By Sales Channel, 2020-2035
11.4.1. Retail Pharmacies
11.4.2. Hospital Pharmacies
11.4.3. Others
11.5. Market Value Forecast By Country / Sub-region, 2020-2035
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Vaccine Type
11.6.2. By Age Group
11.6.3. By Sales Channel
11.6.4. By Country / Sub-region
12. Asia Pacific Respiratory Syncytial Virus Vaccine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Vaccine Type, 2020-2035
12.2.1. Recombinant/Subunit Vaccines
12.2.2. mAB Injection
12.2.3. mRVaccines
12.2.4. Others
12.3. Market Value Forecast By Age Group, 2020-2035
12.3.1. Adults & Geriatrics
12.3.2. Children & Pregnant Mothers
12.4. Market Value Forecast By Sales Channel, 2020-2035
12.4.1. Retail Pharmacies
12.4.2. Hospital Pharmacies
12.4.3. Others
12.5. Market Value Forecast By Country / Sub-region, 2020-2035
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Vaccine Type
12.6.2. By Age Group
12.6.3. By Sales Channel
12.6.4. By Country / Sub-region

13. Latin America Respiratory Syncytial Virus Vaccine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Vaccine Type, 2020-2035
13.2.1. Recombinant/Subunit Vaccines
13.2.2. mAB Injection
13.2.3. mRVaccines
13.2.4. Others
13.3. Market Value Forecast By Age Group, 2020-2035
13.3.1. Adults & Geriatrics
13.3.2. Children & Pregnant Mothers
13.4. Market Value Forecast By Sales Channel, 2020-2035
13.4.1. Retail Pharmacies
13.4.2. Hospital Pharmacies
13.4.3. Others
13.5. Market Value Forecast By Country / Sub-region, 2020-2035
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Vaccine Type
13.6.2. By Age Group
13.6.3. By Sales Channel
13.6.4. By Country / Sub-region
14. Middle East & Africa Respiratory Syncytial Virus Vaccine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Vaccine Type, 2020-2035
14.2.1. Recombinant/Subunit Vaccines
14.2.2. mAB Injection
14.2.3. mRVaccines
14.2.4. Others
14.3. Market Value Forecast By Age Group, 2020-2035
14.3.1. Adults & Geriatrics
14.3.2. Children & Pregnant Mothers
14.4. Market Value Forecast By Sales Channel, 2020-2035
14.4.1. Retail Pharmacies
14.4.2. Hospital Pharmacies
14.4.3. Others
14.5. Market Value Forecast By Country / Sub-region, 2020-2035
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Vaccine Type
14.6.2. By Age Group
14.6.3. By Sales Channel
14.6.4. By Country / Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2024)
15.3. Company Profiles
15.3.1. GSK plc
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. Moderna, Inc.
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Pfizer, Inc.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Sanofi
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. AstraZeneca
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. MAXVAX Biotechnology Limited
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
15.3.7. Guangzhou Patronus Biotech Co., Ltd.
15.3.7.1. Company Overview
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. Business Strategies
15.3.7.5. Recent Developments
15.3.8. Sinocelltech Ltd.
15.3.8.1. Company Overview
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. Business Strategies
15.3.8.5. Recent Developments
15.3.9. Shenzhen Shenxin Biotechnology Co., Ltd
15.3.9.1. Company Overview
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. Business Strategies
15.3.9.5. Recent Developments
15.3.10. Starna Therapeutics
15.3.10.1. Company Overview
15.3.10.2. Financial Overview
15.3.10.3. Product Portfolio
15.3.10.4. Business Strategies
15.3.10.5. Recent Developments
15.3.11. Blue Lake Biotechnology Inc.
15.3.11.1. Company Overview
15.3.11.2. Financial Overview
15.3.11.3. Product Portfolio
15.3.11.4. Business Strategies
15.3.11.5. Recent Developments

List of Tables

Table 01: Global Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Vaccine Type, 2020-2035

Table 02: Global Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 03: Global Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

Table 04: Global Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Region, 2020-2035

Table 05: North America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Country, 2020-2035

Table 06: North America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2020-2035

Table 07: North America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 08: North America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

Table 09: Europe Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035

Table 10: Europe Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2020-2035

Table 11: Europe Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 12: Europe Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

Table 13: Asia Pacific Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035

Table 14: Asia Pacific Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2020-2035

Table 15: Asia Pacific Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 16: Asia Pacific Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

Table 17: Latin America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035

Table 18: Latin America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2020-2035

Table 19: Latin America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 20: Latin America Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

Table 21: Middle East and Africa Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Country/Sub-region, 2020-2035

Table 22: Middle East and Africa Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, by Vaccine Type, 2020-2035

Table 23: Middle East and Africa Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Age Group, 2020-2035

Table 24: Middle East and Africa Respiratory Syncytial Virus Vaccine Market Value (US$ Mn) Forecast, By Sales Channel, 2020-2035

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE

Related Reports

Sleep Apnea Oral Appliances Market by Product (Mandibular Advancement Devices (MAD), Tongue-Retaining Devices (TRD)), Purchase Type (Physician-prescribed), Gender (Male, Female), Age Group, Distribution Channel (Online, Retail) - Global Forecast to 2030
 Market Report I 2025-05-06 I 265 Pages
South Africa Respiratory Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 75 Pages
Anesthesia Monitoring Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 128 Pages

Don't forget we can help save time with your search, contact us and we'll prepare and send options

Global Acute Respiratory Distress Syndrome (ARDS) Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
 Market Report I 2025-04-28 I 130 Pages
Global Anti-Snoring Devices Market - Focused Insights 2025-2030
 Market Report I 2025-04-16 I 135 Pages